Article
Critical Care Medicine
Nicole M. Acquisto, Jarrod M. Mosier, Edward A. Bittner, Asad E. Patanwala, Karen G. Hirsch, Pamela Hargwood, John M. Oropello, Ryan P. Bodkin, Christine M. Groth, Kevin A. Kaucher, Angela A. Slampak-Cindric, Edward M. Manno, Stephen A. Mayer, Lars-Kristofer N. Peterson, Jeremy Fulmer, Christopher Galton, Thomas P. Bleck, Karin Chase, Alan C. Heffner, Kyle J. Gunnerson, Bryan Boling, Michael J. Murray
Summary: This interdisciplinary panel used evidence-based approach to develop a set of recommendations on pharmacologic and nonpharmacologic management for RSI.
CRITICAL CARE MEDICINE
(2023)
Article
Nursing
Helen Anderson, Arabella Scantlebury, Paul Galdas, Joy Adamson
Summary: This study aims to explore how General Practice Nurses implement change during the COVID-19 pandemic and how it affects their professional wellbeing. The study will use a qualitative case study design, collecting data through focus groups and interviews, and analyzing the data using a framework analysis approach. The findings will contribute to improving care delivery and supporting the wellbeing of General Practice Nurses.
JOURNAL OF ADVANCED NURSING
(2022)
Article
Chemistry, Analytical
Catia Marques, Liangwen Liu, Kyle D. Duncan, Ingela Lanekoff
Summary: Targeted and nontargeted metabolomics can evaluate and detect global metabolite changes in biological systems. Direct infusion mass spectrometric analysis can simultaneously provide information on metabolites and lipids in chemically complex samples. The design and characterization of a direct infusion probe (DIP) is presented, which enables rapid metabolomics of chemically complex biological samples. The DIP allows for the acquisition of uniform MS signal for several minutes from low sample volumes, enhancing throughput.
ANALYTICAL CHEMISTRY
(2022)
Letter
Medicine, General & Internal
Kyla A. McKay, Fredrik Piehl, Simon Englund, Anna He, Annette Langer-Gould, Jan Hillert, Thomas Frisell
Summary: This case-control study investigated the risk of severe COVID-19 infection in individuals with multiple sclerosis who were receiving rituximab.
Editorial Material
Urology & Nephrology
Adam D. Morris, Lauren Floyd, Alexander Woywodt, Ajay Dhaygude
Summary: Rituximab may be an effective treatment for primary FSGS, but further research and randomized controlled trials are needed to confirm its efficacy and optimal use.
CLINICAL KIDNEY JOURNAL
(2023)
Article
Oncology
Sorana G. Ursu, Derek L. Rinchuse, John Lister
Summary: The study found that rapid rituximab administration is safe and well tolerated in both benign and malignant diseases, with an incidence of infusion-related reaction at 1.6%. The mean infusion time saved between standard and rapid rituximab administration was 2.9 hours.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
(2021)
Review
Gastroenterology & Hepatology
Jasmohan S. Bajaj, Laura E. Nagy
Summary: Alcohol use and alcohol-associated liver disease have become major burdens during the COVID-19 pandemic. Advances in research have provided important insights into the pathophysiology and clinical consequences of these conditions. This review focuses on case-based approaches that give a human context to these advancements in alcohol-associated liver disease.
Article
Health Care Sciences & Services
Chris Miller-Rosales, Isomi M. Miake-Lye, Amanda L. Brewster, Stephen M. Shortell, Hector P. Rodriguez
Summary: We identified potential orderings of primary care practice adoption of patient engagement strategies by analyzing physician practice survey data. Ordered patterns emerged in the adoption of both interpersonally oriented and technologically oriented strategies.
HEALTH SERVICES RESEARCH
(2022)
Article
Medicine, Research & Experimental
Ana Muntanola, Jose Maria Arguinano-Perez, Julio Davila, Sonia Gonzalez de Villambrosia, Cecilia Carpio, Ana Jimenez-Ubieto, Antonio Salar
Summary: This study retrospectively reviewed the safety and tolerability of rapid 90-min intravenous infusion of SDZ-RTX in patients with CD20+ lymphoma or CLL. The results showed that this rapid infusion schedule was well-tolerated, with no severe adverse reactions during the second and subsequent infusions.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
(2023)
Article
Oncology
Donald C. Moore, Tsion Gebru, Dragos Plesca
Summary: The implementation of a pharmacist-driven protocol significantly improved the utilization of rapid infusion rituximab and optimized chair time utilization at our institution.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Summary: Peptide receptor radionuclide therapy (PRRT) with Lu-177-labeled somatostatin analogs in patients with somatostatin receptor-expressing tumors is often performed using administration protocols prescribing a 30-min infusion time. The study investigated the safety of an infusion time of less than 5 min and found that this faster infusion method is safe and feasible in clinical practice, with mainly grade 1/2 fatigue and grade 1 nausea or vomiting as the clinical toxicities reported.
JOURNAL OF NUCLEAR MEDICINE
(2021)
Review
Oncology
Hannah Christina Puhr, Matthias Preusser, Ayseguel Ilhan-Mutlu
Summary: Recent studies on immunotherapeutic agents for esophageal cancer patients have shown promising results, particularly with checkpoint inhibitors such as nivolumab and pembrolizumab, offering high efficacy, tolerable toxicity, desirable survival rates, and sustained quality of life.
Article
Economics
Marianne Simonsen, Lars Skipper, Niels Skipper, Peter Rono Thingholm
Summary: The study found that while the transition between providers is smooth, there is an increase in medical service fees and a higher likelihood of patients starting drug therapy for chronic diseases. Re-matched patients are more likely to be admitted to inpatient care for diseases.
JOURNAL OF HEALTH ECONOMICS
(2021)
Article
Psychiatry
Lone Baandrup, Anne Mette Dons, Katja Vu Bartholdy, Katrine Overballe Holm, Ida Hageman
Summary: This study aimed to improve the prescribing practice for rapid tranquillization in inpatient mental health care using a quality improvement project and the Plan-Do-Study-Act method. By monitoring medication prescription and administration, the study successfully changed the prescribing practice and improved the quality of treatment.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
(2023)
Article
Dermatology
Dilek Yigit, Ilknur Balta, Hasan Yigit, Hatice Meral Eksioglu
Summary: Rituximab, a chimeric monoclonal antibody, is effective in treating severe pemphigus but can lead to opportunistic infections in immunosuppressed patients. This case report highlights a patient with pemphigus who developed disseminated Nocardia infection following rituximab treatment, ultimately resulting in death due to cardiac arrest. Prolonged rituximab therapy may lead to the development of nocardiosis, emphasizing the importance of weighing risks and benefits in all patients receiving rituximab.
DERMATOLOGIC THERAPY
(2021)
